Opdivo®
Opdivo® (nivolumab) is a prescription medicine administered by intravenous infusion for treatment of 12 different types of cancer by working with your immune system.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Bristol-Myers Squibb |
CLASS: Checkpoint Inhibitors |
PRESCRIBED BY: Oncologists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every four to six weeks |
Length of infusion: 30 mins |
FOR MORE INFORMATION: |
